జర్నల్ ఆఫ్ క్లినికల్ అండ్ ఎక్స్పెరిమెంటల్ ఆప్తాల్మాలజీ
అందరికి ప్రవేశం

నైరూప్య

Treatment for Neovascular Macular Degeneration

Pavan Kumar

Age-related degeneration, a probably bright illness, is currently epidemic within the developed world. Roughly one in 3 individuals are affected to some extent by the age of seventy five years. Medicine's tremendous successes within the battles against cancer, diabetes, cardiovascular disease, cardiovascular disease, and alternative common killers have raised the typical anticipation in several countries to over seventy five years and in therefore doing have unwittingly delivered a replacement scourge to humankind. In this issue of the Journal, DE Jong2 discusses age-related degeneration as a fancy disorder that begins decades before a patient becomes symptomatic, a molecular derangement.